Health Care & Life Sciences » Pharmaceuticals | Corium International Inc.

Corium International Inc.

Corium International Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.57
Market Cap
$342.93 M
Shares Outstanding
36.25 M
Public Float
26.14 M

Profile

Address
235 Constitution Drive
Menlo Park California 94025
United States
Employees -
Website http://www.coriumgroup.com
Updated 09/14/2018
Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor.

Financials

View All

David L. Greenwood
Executive Chairman
Peter D. Staple
President, Chief Executive Officer & Director